title: Expression of NTPDase1 and NTPDase2 in murine kidney: relevance to regulation of P2 receptor signaling.
abstract: The regulation of renal function by extracellular nucleotides encompasses alterations in glomerular hemodynamics, microvascular function, tubuloglomerular feedback, tubular transport, cell growth or apoptosis, and transport of water and solutes in the medullary collecting duct. Nearly all cells can release ATP or other nucleotides that are then rapidly hydrolyzed in the extracellular milieu. However, little information is available on the cellular expression of ectoenzymes that hydrolyze extracellular nucleotides within the kidney. Nucleoside triphosphate diphosphohydrolases (NTPDases) are plasma membrane-bound ectonucleotidases. NTPDase1 has identity with CD39, a B lymphocyte activation marker, and hydrolyzes extracellular ATP and ADP to AMP within the vasculature, whereas NTPDase2/CD39L(ike)1 preferentially converts ATP to ADP outside of blood vessels. Using immunohistochemical and in situ hybridization approaches, we localized the protein and mRNA of NTPDase1 and 2 in murine renal tissues. In the renal cortex, NTPDase1 is expressed by vascular smooth muscle cells and endothelium in interlobular arteries, afferent glomerular arterioles, and peritubular capillaries. In the inner medulla, NTPDase1 is expressed in ascending thin limbs of Henle's loop, ducts of Bellini, and in the pelvic wall. In contrast, NTPDase2 is expressed in Bowman's capsule, glomerular arterioles, adventitia of blood vessels, and pelvic wall. Thus the distribution patterns of NTPDases have parallels to the known distribution of P2 receptors within the kidney. NTPDases may modulate regulatory effects of ATP and degradation products within the vasculature and other sites and thereby potentially influence physiological as well as multiple pathological events in the kidney.
authors.affiliation: Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake CIty, Utah, USA. Bellamkonda.Kishore@hsc.utah.edu
authors.forename: Bellamkonda K
authors.initials: BK
authors.lastname: Kishore
authors.forename: Jorge
authors.initials: J
authors.lastname: Isaac
authors.forename: Michel
authors.initials: M
authors.lastname: Fausther
authors.forename: Sheryl R
authors.initials: SR
authors.lastname: Tripp
authors.forename: Huihui
authors.initials: H
authors.lastname: Shi
authors.forename: Pritmohinder S
authors.initials: PS
authors.lastname: Gill
authors.forename: Norbert
authors.initials: N
authors.lastname: Braun
authors.forename: Herbert
authors.initials: H
authors.lastname: Zimmermann
authors.forename: Jean
authors.initials: J
authors.lastname: Sévigny
authors.forename: Simon C
authors.initials: SC
authors.lastname: Robson
mesh_terms: D000251:Adenosine Triphosphatases / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D000818:Animals; D000918:Antibody Specificity; D015703:Antigens, CD / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D001081:Apyrase; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D007668:Kidney / Q000201:enzymology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D015347:RNA Probes; D012333:RNA, Messenger / Q000032:analysis; D018048:Receptors, Purinergic P2 / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D015703:Antigens, CD; D015347:RNA Probes; D012333:RNA, Messenger; D018048:Receptors, Purinergic P2; D000251:Adenosine Triphosphatases; C027201:ectoATPase; D001081:Apyrase; C067869:CD39 antigen